Like many authors, I keep track of where I'm cited. So I was a bit surprised to see I had been referenced in a paper in the Agricultural Association of Textile Chemical and Critical Reviews Journal: https://doi.org/10.21276/AATCCReview.2026.14.03.22 Not the usual journal I expect. But even more curious, the title of the paper is "An overview of qua...
After premiering this event at ADLM, we are opening it up to everyone through zoom. Please join us September 25th, at 11 am central standard time. At last, a frank look at why we need to do less QC, and how we can make those reductions safely. If you enjoy being out of control every day, if you get a thrill every time you have to repeat a con...
New Download: Sigma-Metrics Tool (and audioconference presentation)
On September 4th, 2008, Dr. Westgard spoke as part of the AACC audioconference on "New Directions in Laboratory QC" - which was subsequently quoted in the Clin Lab News article on Risk and CLIA. We are pleased to make available Dr. Westgard's complete presentation, as well as two Sigma-metrics Charts and instructions on how to use them in QC Design.
Westgard Sigma Analysis: A new direct HbA1c Method
At the 2008 AACC/ASCLS convention, a poster was presented for a new direct enzymatic assay for %HbA1c. How does it stack up against HPLC and immunoassay methods? How do you judge a method when you've got multiple comparison methods and multiple quality requirements?
Interview: Dr. R. Neill Carey (A brief introduction to EP 15)
We were fortunate to get R. Neill Carey, PhD, the chair of the CLSI EP 15 committee, to present and
explain that new standard at the Chicago Method Validation workshop. He also contributed a chapter to the new Basic Method Validation manual on the same topic. But for those who have never heard of EP 15 before, we conducted a short interview with Dr. Carey. This short introduction to EP 15 may pique your interest in this new guideline.
Thinking about Three Sigma: 2 thoughts on troublesome performance
In a previous lesson, we discussed some possible actions to take when the Sigma-metric for a method is higher than Six. But what about those methods with low Sigma-metrics? What do you do when Sigma analysis delivers bad news?
Posted by Sten Westgard
One of the highlights for me of the AACC convention in Washington, DC, was my inclusion in a poster that analyzed the method performance of the Abbott Architect c8000. I'm pictured here with fellow authors (left to right) Gene Osikowicz, Charles Wilson, and John Baker (lead author). They deserve most of the credit for the work of collecting the data.
The poster can be viewed here and the QC application on Westgard Web can be viewed here. -----
Posted by Sten Westgard, MS
Posted by Sten Westgard, MS
Thanks to our hosts, our partnets, and our participants in Medellin, Colombia!
(more, after the jump)
-----
Posted by Sten Westgard, MS
Posted by Sten Westgard, MS
At the AACC/ASCLS conference in San Diego, many of the Sigma VP laboratories contributed to a poster on evaluating the applicability of various analytical performance specifications for AST:
Multisite study of AST analytical performance reveals disparities in global performance specifications
The full poster can be downloaded from our westgard.com download section here. (free membership required)
But what was most rewarding was meeting with many of the co-authors who came to the meeting.
Ms Ginny Foo, Mr. Rajkumar Rengaraju, Co-authors from Innovative Diagnostics, Singapore
more pictures after the jump
-----
Posted by Sten Westgard, MS
Posted by Sten Westgard, MS
Posted by Sten Westgard, MS
Posted by Sten Westgard, MS
We got the following question emailed to the website recently:
Greetings, I was [wondering] if the following case represents [violation] of 4 1s rule?
Control (A) point 1= EXCEEDS 2 SD /-2 SD lines >> warning
Control (A) point 2= WITHIN 2 SD/-2 SD lines >> accepted
Control (A) point 3= EXCEEDS 2 SD /-2 SD lines >> warning
Control (A) point 4= WITHIN 2 SD/-2 SD lines >> rejection
all the point[s] on the same side of the mean.
What do you think? The answer, after the jump
-----
Posted by Sten Westgard, MS
Posted by Sten Westgard, MS